Effects of L-carnitine supplementation on oxidative stress and antioxidant enzymes activities in patients with coronary artery disease: A randomized, placebo-controlled trial

Nutrition Journal

Volumn 13, Issue 1, 2014, Pages

  Lee, Bor Jen ^a   Lin, Jun Shuo ^b   Lin, Yi Chin ^b,c   Lin, Ping Ting ^b,c  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Antioxidant enzymes; Coronary artery disease; L carnitine; Oxidative stress

Indexed keywords

CARNITINE; CATALASE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; PLACEBO; SUPEROXIDE DISMUTASE; ANTIOXIDANT; BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DISEASE COURSE; DRUG BLOOD LEVEL; ENZYME ACTIVITY; FEMALE; HEART CATHETERIZATION; HUMAN; MALE; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SUPPLEMENTATION; BLOOD; BODY MASS; CORONARY ARTERY DISEASE; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; MIDDLE AGED; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIOXIDANTS; BIOLOGICAL MARKERS; BODY MASS INDEX; CARNITINE; CATALASE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; SINGLE-BLIND METHOD; SUPEROXIDE DISMUTASE; TRIGLYCERIDES;

EID: 84906511051     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-13-79     Document Type: Article

References (35)

1. Shattuck lecture-cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. Braunwald E, N Engl J Med 1997 337 1360 1369 10.1056/NEJM199711063371906 9358131
2. Role of oxidative stress in atherosclerosis. Harrison D, Griendling KG, Landmesser U, Hornig B, Drexlar H, Am J Cardio 2003 91 7 11 10.1016/S0002-9149(02)03144-2
3. Nutritional treatments for acute myocardial infarction. Gaby AR, Altern Med Rev 2010 15 113 123 20806996
4. Carnitine: an overview of its role in preventive medicine. Kendler BS, Prev Med 1986 15 373 390 10.1016/0091-7435(86)90005-8 3532087
5. Role of carnitine in disease. Flanagan JL, Simmons PA, Vehige J, Willcox MD, Garrett Q, Nutr Metab 2010 7 30 10.1186/1743-7075-7-30
6. Carnitine metabolism and function. Bremer J, Physiol Rev 1983 63 1420 1479 6361812
7. L-carnitine ameliorates oxidative damage due to chronic renal failure in rats. Sener G, Paskaloʇlu K, Satiroglu H, Alican I, Kac¸maz A, Sakarcan A, J Cardiovasc Pharmacol 2004 43 698 705 10.1097/00005344-200405000-00013 15071358
8. Antioxidant and antiradical activities of L-carnitine. Gülc¸in I, Life Sci 2006 78 803 811 10.1016/j.lfs.2005.05.103 16253281
9. L-Carnitine protects plasma components against oxidative alterations. Kolodziejczyk J, Saluk-Juszczak J, Wachowicz B, Nutrition 2011 27 693 699 10.1016/j.nut.2010.06.009 20869209
10. Single dose administration of L-carnitine improve antioxidant activities in human subjects. Cao Y, Qu HJ, Li P, Wang CB, Wang LX, Han ZW, Tohoku J Exp Med 2011 224 209 213 10.1620/tjem.224.209 21701126
11. A randomised, double-blind, placebo-controlled trial of L-carnitine in suspected acute myocardial infarction. Singh RB, Niaz MA, Agarwal P, Beegum R, Rastogi SS, Sachan DS, Postgrad Med J 1996 72 45 50 10.1136/pgmj.72.843.45 8746285
12. L-carnitine administration in coronary artery disease and cardiomyopathy. Singh RB, Aslam M, J Assoc Physicians India 1998 46 801 805 11229253
13. Influence of L-carnitine and its derivatives on myocardial metabolism and function in ischemic heart disease and during cardiopulmonary bypass. Lango R, Smolenski RT, Narkiewicz M, Suchorzewska J, Lysiak-Szydlowska W, Cardiovasc Res 2001 51 21 29 10.1016/S0008-6363(01)00313-3 11399244
14. Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT study. Walter MF, Jacob RF, Jeffers B, Ghadanfar MM, Preston GM, Buch J, Mason RP, PREVENT study, J Am Coll Cardiol 2004 44 1996 2002 10.1016/j.jacc.2004.08.029 15542282
15. Biological markers of oxidative stress: Applications to cardiovascular research and practice. Ho E, Karimi Galougahi K, Liu CC, Bhindi R, Figtree GA, Redox Biol 2013 1 483 491 10.1016/j.redox.2013.07.006 24251116
16. Rapid, sensitive, and specific thiobarbituric acid method for measuring lipid peroxidation in animal tissue, food and feedstuff samples. Botsoglou NA, J Agric Food Chem 1994 42 1931 1937 10.1021/jf00045a019
17. Studies on the qualitative characterization of erythrocyte glutathione peroxidase. Paglia D, Valentine W, J Lab Clin Med 1967 70 159 169
18. Involvement of superoxide anion radical in autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Marklund S, Marklund G, Eur J Biochem 1974 47 469 474 10.1111/j.1432-1033.1974.tb03714.x 4215654
19. Catalase in vitro. Aebi H, Methods Enzymol 1984 105 121 126 6727660
20. Erythrocyte antioxidant systems protect cultured endothelial cells against oxidant damage. Richards RS, Roberts TK, Dunstan RH, McGregor NR, Butt HL, Biochem Mol Biol Int 1998 46 857 865 9861439
21. L-carnitine and its propionate: improvement of endothelial function in SHR through superoxide dismutase-dependent mechanisms. de Sotomayor MA, Mingorance C, Rodriguez-Rodriguez R, Marhuenda E, Herrera MD, Free Radic Res 2007 41 884 891 10.1080/10715760701416467 17654045
22. L-carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders. Ribas GS, Vargas CR, Wajner M, Gene 2014 533 469 476 10.1016/j.gene.2013.10.017 24148561
23. Quantitation of the effect of L-carnitine on the levels of acid-soluble short-chain acyl-CoA and CoASH in rat heart and liver mitochondria. Lysiak W, Lilly K, DiLisa F, Toth PP, Bieber LL, J Biol Chem 1988 263 1151 1156 3335535
24. Carnitine stimulation of glucose oxidation in the fatty acid perfused isolated working rat heart. Broderick TL, Quinney HA, Lopaschuk GD, J Biol Chem 1992 267 3758 3763 1740427
25. Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders. Mingorance C, Rodríguez-Rodríguez R, Justo ML, Alvarez de Sotomayor M, Herrera MD, Vasc Health Risk Manag 2011 7 169 176 21490942
26. Lipids of physiologic significance. Botham KM, Mayes PA, Harper's Illustrated Biochemistry. Chapter 15 New York: McGraw-Hill Companies, Murray RK, Bender DA, Botham KM, Kennelly PJ, Rodwell VW, Weil PA, 29 2012
27. Role of oxidative stress in cardiovascular diseases. Dhalla NS, Temsah RM, Netticadan T, J Hypertens 2000 18 655 673 10.1097/00004872-200018060-00002 10872549
28. Role ofoxidative stress in atherosclerosis. Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H, Am J Cardiol 2003 91 7A 11A 10.1016/S0002-9149(02)03144-2 12645638
29. Atherosclerosis: the road ahead. Glass CK, Witztum JL, Cell 2001 104 503 516 10.1016/S0092-8674(01)00238-0 11239408
30. Oxidative stress in cardiovascular disease. Successful translation from bench to beside? Schnabel R, Stefan B, Circulation 2007 116 1338 1340 10.1161/CIRCULATIONAHA.107.728394 17875978
31. Nutrition treatments for acute myocardial infarction. Guby AR, Altern Med Rev 2010 15 113 123 20806996
32. Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies. Johri AM, Heyland DK, Hétu MF, Crawford B, Spence JD, Nutr Metab Cardiovasc Dis 2014 in press
33. Myocardial carnitine deficiency in acute myocardial infarction. Spagnoli LG, Corsi M, Villaschi S, Palmieri G, Maccari F, Lancet 1982 1 1419 1420
34. Myocardial carnitine deficiency in chronic heart failure. Suzuki Y, Masumura Y, Kobayashi A, Yamazaki N, Harada Y, Osawa M, Lancet 1982 1 116 6119489
35. L-carnitine consumption, its metabolism by intestinal microbiota, and cardiovascular health. McCarty MF, Mayo Clin Proc 2013 88 786 789 10.1016/j.mayocp.2013.06.004 23910406